تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,415,485 |
تعداد دریافت فایل اصل مقاله | 11,291,272 |
Hereditary Angioedema Due to C1-Inhibitor Deficiency in Romania: First National Study, Diagnostic and Treatment Challenges | ||
Iranian Journal of Immunology | ||
دوره 17، شماره 3، آذر 2020، صفحه 226-235 اصل مقاله (891.51 K) | ||
نوع مقاله: Original Article | ||
شناسه دیجیتال (DOI): 10.22034/iji.2020.85416.1709 | ||
نویسندگان | ||
Gabriella Gabos1؛ Valentin Nadasan* 2؛ Eniko Mihaly3؛ Daniela Dobru4 | ||
1Lotus Life Clinic, Târgu Mureș, Romania | ||
2Romanian Network for Hereditary Angioedema; Department of Hygiene, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania. | ||
3Allergology and Immunology Department, Mures County Hospital, Targu Mures, Romania | ||
4Gastroenterology Department, Mures County Hospital, Targu Mures, Romania; Department of Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania | ||
چکیده | ||
Background: Hereditary angioedema (HAE) is a rare genetic potentially life-threatening disease characterized by episodic non-pruritic subcutaneous and submucosal edema attacks in different parts of the body. Objective: To assess the status of Romanian HAE patients after the recent introduction of a new therapy through a nationwide program. Methods: This cross-sectional observational study included patients from the Romanian HAE Registry. Results: The study included 84 patients with HAE type I (91.7%) and type II (8.3%). The mean delay in diagnosis was 2.4 years in children and 16.7 years in adults (p=0.019). Stress and tiredness were the most frequent trigger factors. The majority of the HAE episodes involved subcutaneous (89.3%), abdominal (77.4%), genital (51.2%), facial (41.7%), and laryngeal (39.3%) symptoms during the preceding 12 months. One or several misdiagnoses were reported in 83.33% patients and 44.1 % of the patients were subjected to or proposed unnecessary surgery during abdominal episodes. Plasma-derived C1-INH (pdC1-INH) and recombinant C1-INH (rhC1-INH) were respectively used in 10 (11.9%) and 13 (15.5%) of the HAE patients for life-threatening attacks over the past 12 months. Fortythree (51.19%) patients practiced home treatment with subcutaneous injection of the bradykinin B2-receptor antagonist for acute HAE attacks. Conclusion: The significantly lower delay observed in children suggests an improvement in the awareness of C1-INH-HAE among physicians in recent years. The management of HAE in Romania has been somewhat enhanced as the majority of HAE patients have recently gained access to pdC1-INH, rhC1-INH, and bradykinin B2-receptor antagonist. | ||
کلیدواژهها | ||
Angioedema؛ Diagnostic Errors؛ Hereditary؛ Romania | ||
آمار تعداد مشاهده مقاله: 843 تعداد دریافت فایل اصل مقاله: 528 |